302 related articles for article (PubMed ID: 12802758)
1. Adherence to directly observed antiretroviral therapy among human immunodeficiency virus-infected prison inmates.
Wohl DA; Stephenson BL; Golin CE; Kiziah CN; Rosen D; Ngo B; Liu H; Kaplan AH
Clin Infect Dis; 2003 Jun; 36(12):1572-6. PubMed ID: 12802758
[TBL] [Abstract][Full Text] [Related]
2. A pilot study of health beliefs and attitudes concerning measures of antiretroviral adherence among prisoners receiving directly observed antiretroviral therapy.
White BL; Wohl DA; Hays RD; Golin CE; Liu H; Kiziah CN; Simpson G; Kaplan AH
AIDS Patient Care STDS; 2006 Jun; 20(6):408-17. PubMed ID: 16789854
[TBL] [Abstract][Full Text] [Related]
3. Adherence to antiretroviral therapy by human immunodeficiency virus-infected patients.
Turner BJ
J Infect Dis; 2002 May; 185 Suppl 2():S143-51. PubMed ID: 12001036
[TBL] [Abstract][Full Text] [Related]
4. Nonadherence with pediatric human immunodeficiency virus therapy as medical neglect.
Roberts GM; Wheeler JG; Tucker NC; Hackler C; Young K; Maples HD; Darville T
Pediatrics; 2004 Sep; 114(3):e346-53. PubMed ID: 15342896
[TBL] [Abstract][Full Text] [Related]
5. Hospital-based directly observed therapy for HIV-infected children and adolescents to assess adherence to antiretroviral medications.
Glikman D; Walsh L; Valkenburg J; Mangat PD; Marcinak JF
Pediatrics; 2007 May; 119(5):e1142-8. PubMed ID: 17452493
[TBL] [Abstract][Full Text] [Related]
6. Adherence to antiretroviral therapy among HIV-infected prison inmates (Spain).
Soto Blanco JM; Pérez IR; March JC
Int J STD AIDS; 2005 Feb; 16(2):133-8. PubMed ID: 15807941
[TBL] [Abstract][Full Text] [Related]
7. Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in Botswana.
Vriesendorp R; Cohen A; Kristanto P; Vrijens B; Rakesh P; Anand B; Iwebor HU; Stiekema J
Eur J Clin Pharmacol; 2007 Dec; 63(12):1115-21. PubMed ID: 17882408
[TBL] [Abstract][Full Text] [Related]
8. Directly observed therapy for the treatment of people with human immunodeficiency virus infection: a work in progress.
Mitty JA; Stone VE; Sands M; Macalino G; Flanigan T
Clin Infect Dis; 2002 Apr; 34(7):984-90. PubMed ID: 11880965
[TBL] [Abstract][Full Text] [Related]
9. A randomized trial of directly administered antiretroviral therapy and adherence case management intervention.
Wohl AR; Garland WH; Valencia R; Squires K; Witt MD; Kovacs A; Larsen R; Hader S; Anthony MN; Weidle PJ
Clin Infect Dis; 2006 Jun; 42(11):1619-27. PubMed ID: 16652320
[TBL] [Abstract][Full Text] [Related]
10. Value of patient self-report and plasma human immunodeficiency virus protease inhibitor level as markers of adherence to antiretroviral therapy: relationship to virologic response.
Duong M; Piroth L; Peytavin G; Forte F; Kohli E; Grappin M; Buisson M; Chavanet P; Portier H
Clin Infect Dis; 2001 Aug; 33(3):386-92. PubMed ID: 11438909
[TBL] [Abstract][Full Text] [Related]
11. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal antiretroviral adherence among adolescents infected with human immunodeficiency virus.
Murphy DA; Belzer M; Durako SJ; Sarr M; Wilson CM; Muenz LR;
Arch Pediatr Adolesc Med; 2005 Aug; 159(8):764-70. PubMed ID: 16061785
[TBL] [Abstract][Full Text] [Related]
13. A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV.
Grossberg R; Zhang Y; Gross R
J Clin Epidemiol; 2004 Oct; 57(10):1107-10. PubMed ID: 15528063
[TBL] [Abstract][Full Text] [Related]
14. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and tolerability of a once-daily amprenavir/ritonavir-containing highly active antiretroviral therapy regimen in antiretroviral-naïve patients at risk for nonadherence: 48-week results after 24 weeks of directly observed therapy.
Jayaweera DT; Kolber MA; Brill M; Tanner T; Campo R; Rodriguez A; Chu HM; Garg V
HIV Med; 2004 Sep; 5(5):364-70. PubMed ID: 15369512
[TBL] [Abstract][Full Text] [Related]
16. Medication adherence in patients with HIV infection: a comparison of two measurement methods.
Melbourne KM; Geletko SM; Brown SL; Willey-Lessne C; Chase S; Fisher A
AIDS Read; 1999 Aug; 9(5):329-38. PubMed ID: 12737122
[TBL] [Abstract][Full Text] [Related]
17. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
18. Antiretroviral prescribing patterns in the Texas prison system.
Baillargeon J; Borucki MJ; Zepeda S; Jenson HB; Leach CT
Clin Infect Dis; 2000 Dec; 31(6):1476-81. PubMed ID: 11096015
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with accurate self-reported adherence to HIV antiretrovirals.
Kimmerling M; Wagner G; Ghosh-Dastidar B
Int J STD AIDS; 2003 Apr; 14(4):281-4. PubMed ID: 12716500
[TBL] [Abstract][Full Text] [Related]
20. Predictors of short-term success of antiretroviral therapy in HIV infection.
Oette M; Kroidl A; Göbels K; Stabbert A; Menge M; Sagir A; Kuschak D; O'hanley T; Bode JG; Häussinger D
J Antimicrob Chemother; 2006 Jul; 58(1):147-53. PubMed ID: 16687458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
